Related Experiment Videos
Antitumor response of CD14+/CD16+ monocyte subpopulation
Anna Szaflarska1, Monika Baj-Krzyworzeka, Maciej Siedlar
1Department of Clinical Immunology, Polish-American Institute of Pediatrics, Jagiellonian University Medical College, Cracow, Poland.
Experimental Hematology
|August 17, 2004
Summary
The CD14+/CD16+ monocyte subpopulation significantly enhances antitumor responses by producing key cytokines and reactive nitrogen intermediates, alongside increased cytotoxic activity against tumor cells.
Area of Science:
- Immunology
- Cell Biology
Background:
- Human blood monocytes comprise two main subpopulations: CD14++ and CD14+/CD16+.
- Monocytes and macrophages play a crucial role in the host's antitumor immune response.
Purpose of the Study:
- To investigate the capacity of CD14+/CD16+ monocytes to produce cytokines and reactive oxygen/nitrogen intermediates (ROI, RNI) upon in vitro stimulation with tumor cells.
Main Methods:
- Monocytes were isolated and sorted using elutriation and FACS.
- Co-culture experiments with monocytes and tumor cells were performed.
- Cytokine production, ROI, and RNI generation were assessed using flow cytometry, ELISA, and colorimetric assays.
Main Results:
- CD14+/CD16+ monocytes demonstrated significantly enhanced production of TNF-alpha, IL-12p40, and IL-12p70.
- Increased inducible NO synthase (iNOS) expression and nitric oxide (NO) release were observed, with no ROI production.
- These monocytes exhibited augmented cytotoxic and cytostatic effects on tumor cells.
Conclusions:
- The CD14+/CD16+ monocyte subpopulation is a key player in antitumor immunity.
- Enhanced production of pro-inflammatory cytokines, RNI, and increased cytotoxic/cytostatic activity characterize this subpopulation's role.